Corcept Therapeutics Inc’s recent filing unveils that its Director Swisher Daniel N JR acquired Company’s shares for reported $0.12 million on Mar 10 ’25. In the deal valued at $53.60 per share,2,200 shares were bought.
Then, Maduck Sean sold 18,303 shares, generating $1,110,818 in total proceeds. Upon selling the shares at $60.69, the insider now owns 85,622 shares.
Before that, Lyon Joseph Douglas sold 4,579 shares. Corcept Therapeutics Inc shares valued at $277,902 were divested by the insider at a price of $60.69 per share. As a result of the transaction, Lyon Joseph Douglas now holds 9,009 shares, worth roughly $0.5 million.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Tuesday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock fall -1.74% to $55.42. Over the last five days, the stock has lost -1.02%. Corcept Therapeutics Inc shares have risen nearly 9.98% since the year began. Nevertheless, the stocks have risen 137.04% over the past one year. While a 52-week high of $75.00 was reached on 02/19/25, a 52-week low of $20.84 was recorded on 01/13/25. SMA at 50 days reached $60.09, while 200 days put it at $46.15.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 54.45, which if violated will result in even more drops to 53.49. On the upside, there is a resistance level at 56.97. A further resistance level may holdings at 58.53. The Relative Strength Index (RSI) on the 14-day chart is 37.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.37, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.22%. Stochastics %K at 14.79% indicates the stock is a buying.
